Corporate Overview

Clene is revolutionizing the treatment of neurodegenerative disease with an innovative nanotherapeutic platform to generate first-in-class elemental nanomedicines designed to optimize neurorepair and health through energy-enhancing bioenergetic catalysis.

Why Invest

Introducing a New Paradigm in Neurodegenerative Medicine

Effective treatment of patients with neurodegenerative disorders requires a therapeutic breakthrough. The incidence of neurodegenerative diseases continues to increase as the global population ages and the World Health Organization (WHO) predicts that these diseases will become the second-most prevalent cause of death within the next 20 years.

Bioenergetic Approach

Clene has created new classes of drugs using biologically active nanocrystals to catalyze reactions within the body, enhancing cellular repair and treating neurodegeneration.

health insurance

Clene carefully engineered its lead candidate, CNM-Au8, as a bioenergetic nanocatalyst to enhance critical intracellular bioenergetic reactions necessary for repairing and reversing neuronal damage.

View all news

Latest News

View all events

Latest Events

View all presentations

Latest Presentation